|
XOMA Appoints W. Denman Van Ness as Lead Independent Director |
|
XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced today that its Board of Directors has appointed current board member W. Denman Van Ness as Lead Independent Director.
Read more: . |